 |
|
Further Characterization of the DFNA1 Audiovestibular Phenotype
Anil K. Lalwani, MD;
Robert K. Jackler, MD;
Robert W. Sweetow, PhD;
Eric D. Lynch, PhD;
Henriette Raventós, MD;
Jan Morrow, MS;
Mary-Claire King, PhD;
Pedro E. León, PhD
Arch Otolaryngol Head Neck Surg. 1998;124:699-702.
Background Autosomal dominant, nonsyndromic, hereditary hearing impairment in a large Costa Rican kindred is caused by a mutation in the human homolog of the Drosophila diaphanous gene.
Objective To further characterize the phenotype of DFNA1 with comprehensive audiovestibular evaluation and computed tomography of the temporal bone.
Patients One affected child and 2 affected adults of the Costa Rican kindred who harbor a mutation in the diaphanous gene.
Setting Medical Center at the University of California, San Francisco.
Intervention Otologic and neuro-otologic examination; pure tone audiometry, speech audiometry, and immitance testing; auditory evoked potentials, electrocochleography, and otoacoustic emissions; electronystagmography and vestibular autorotation tests; and computed tomography of the temporal bone.
Results The youngest subject, an 8-year-old boy, had a mild hearing loss, intact stapedial reflexes, otoacoustic emissions at high frequencies, normal auditory evoked potentials, and electrocochleographic findings consistent with endolymphatic hydrops. The two adults had severe to profound bilateral sensorineural hearing impairment. Electronystagmography disclosed normal vestibular function. Computed tomography demonstrated normal external, middle, and inner ear structures.
Conclusions These results suggest that the early low-frequency hearing loss in this family is associated with endolymphatic hydrops. Elucidation of the role of the diaphanous gene in hearing will therefore lead to a better understanding of the mechanism of endolymphatic hydrops.
From the Department of Otolaryngology–Head and Neck Surgery, University of California, San Francisco (Drs Lalwani, Jackler, and Sweetow); the Departments of Medicine and Genetics, University of Washington, Seattle (Drs Lynch and King and Ms Morrow); and the School of Medicine, and Center for Research and Molecular Biology, University of Costa Rica, San Jose, Costa Rica (Drs Raventós and León).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Modifier controls severity of a novel dominant low-frequency MyosinVIIA (MYO7A) auditory mutation
Street et al.
J. Med. Genet. 2004;41:e62-e62.
FULL TEXT
Mutations in the Wolfram Syndrome Type 1 Gene (WFS1) Define a Clinical Entity of Dominant Low-Frequency Sensorineural Hearing Loss
Lesperance et al.
Arch Otolaryngol Head Neck Surg 2003;129:411-420.
ABSTRACT
| FULL TEXT
Progression of Low-Frequency Sensorineural Hearing Loss (DFNA6/14-WFS1)
Pennings et al.
Arch Otolaryngol Head Neck Surg 2003;129:421-426.
ABSTRACT
| FULL TEXT
|
